Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 5:3:1504.
doi: 10.12688/gatesopenres.13042.2. eCollection 2019.

Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up

Sushena Reza-Paul #  1   2 , Lisa Lazarus #  1 , Smarajit Jana  3 , Protim Ray  3 , Nelly Mugo  4   5 , Kenneth Ngure  6 , Morenike Oluwatoyin Folayan  7 , Florita Durueke  8 , John Idoko  9 , Luc Béhanzin  10   11   12 , Michel Alary  10   13   14 , Daouda Gueye  15 , Moussa Sarr  16 , Wanjiru Mukoma  17 , Jordan K Kyongo  17 , Rutendo Bothma  18 , Robyn Eakle  18   19 , Gina Dallabetta  20 , Josie Presley  21 , Robert Lorway  1
Affiliations

Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up

Sushena Reza-Paul et al. Gates Open Res. .

Abstract

Pre-exposure prophylaxis (PrEP) has emerged as a new HIV prevention strategy. A series of demonstration projects were conducted to explore the use of PrEP outside of clinical trial settings. Learning from the failures in community consultation and involvement in early oral tenofovir trials, these PrEP projects attempted to better engage communities and create spaces for community involvement in the planning and roll out of these projects. We briefly describe the community engagement strategies employed by seven Bill & Melinda Gates Foundation-funded PrEP demonstration projects and the lessons these projects offer for community engagement in PrEP implementation.

Keywords: HIV; demonstration projects; pre-exposure prophylaxis; prevention; serodiscordant couples; sex work.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

References

    1. CDC: Pre-Exposure Prophylaxis (PrEP) for HIV Prevention.2014. Reference Source
    1. World Health Organization: Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects.2012. Reference Source - PubMed
    1. World Health Organization: Pre-exposure prophylaxis.2015. Reference Source - PubMed
    1. Baeten JM, Donnell D, Ndase P, et al. : Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. 10.1056/NEJMoa1108524 - DOI - PMC - PubMed
    1. Choopanya K, Martin M, Suntharasamai P, et al. : Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90. 10.1016/S0140-6736(13)61127-7 - DOI - PubMed